News

Prof. Coen Rasch Joins Advisory Board Sensius

Sensius is proud to announce Prof.Dr. Coen Rasch as a member of its Advisory Board. Coen is a radiation oncologist ...
Read More

Sensius Appoints Rik Kielman as Marketing and Sales Director

Sensius has appointed Rik Kielman as Marketing and Sales Director. Rik studied Business Management in Groningen, the Netherlands. After his ...
Read More

Sensius Awarded in China

During the The 5th Zhejiang University Alumni Entrepreneurship Competition, Sensius was awarded as the most exciting foreign startup. Genetic cancer ...
Read More

3rd Annual ESHO Sensius Young Investigators Award

Sponsored by Sensius, the European Society for Hyperthermic Oncology (ESHO) has awarded the Young Investigators Award to Morteza Ghaderi Aram ...
Read More

Sensius unveils new applicator design

Warsaw, 22 May 2019 Using novel technology, developed by Erasmus MC and TU-Delft, Sensius has redesigned the Head and Neck ...
Read More

Erasmus MC and Sensius sign license agreement on innovative bolus technology

Prof. Gerard van Rhoon, Paul van den Biggelaar and Prof. Pieter Sonneveld Prof. P. Sonneveld, chair of the department of ...
Read More

WBAF 2019 Hears Proposition Sensius First

At the World Business Angels Investment Forum 2019 in Istanbul, Turkey (19-20 February 2019), Sensius is the first company to ...
Read More

SIOG2018 Reward for Study Proposal Thermotherapy for Primary H&N Cancer

Dr. Mandy Kiderlen has been awarded with the SIOG 2018 Young Research Prize for her presentation of the proposal regarding ...
Read More

EBAN votes Sensius Winner of Winter Summit 2018

Luxembourg, 23 October 2018 Members of EBAN, the European Business Angel Network, voted Sensius to be the winner of the ...
Read More

Sensius Winner of Dutch Start JLM2018 competition

The Israeli ambassador, His Excellence Aviv Shir-On, presented the winner's plaque to Sensius after a pitching contest at the brand ...
Read More

Germany adds Hyperthermia to Treatment of Sarcomas in Certification Pilot

The most recent questionnaire for sarcoma centers as published by the DKG, the German Cancer Society, now includes the requirement ...
Read More

Maarten Paulides appointed Scientific Director C3TE TU-Eindhoven

The Technical University Eindhoven has appointed Maarten Paulides, co-founder of Sensius, to be the new scientific director of the Center ...
Read More
Sensius: First joint EBAN Scaleup of the month May-2018

Sensius: First joint EBAN Scaleup of the month May-2018

31 May 2018 On May 31, 2018 the European Business Angels Network (EBAN) and the European Agency for Small and ...
Read More
2nd Annual ESHO Sensius Young Investigators Award

2nd Annual ESHO Sensius Young Investigators Award

19 May, 2018 Sensius is sponsor of the European Society for Hyperthermic Oncology (ESHO). During the annual conference in May ...
Read More
New! Advisory Board Sensius

New! Advisory Board Sensius

1 May, 2018 In May 2018 Sensius established an Advisory Board with board members with specific knowledge and experience on ...
Read More

Sensius won the Venture Cup Award of Startup Olé Salamanca

19 April 2018 Sensius won the Venture Cup Award of Startup Olé SalamancaCompanies with the European Seal of Excellence from ...
Read More
Interview Life Sciences & Health 010 magazine

Interview Life Sciences & Health 010 magazine

February 2018 In December 2017 our CEO Paul van den Biggelaar was interviewed by the Life Sciences & Health 010 ...
Read More

Pitch during Innovation for Health

Februari 2018 In February 2018 Sensius was invited for a pitch among other Dutch innovative startups during the congress Innovation ...
Read More

“High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer”

Rotterdam, 24 December 2017 MedValue: “High Interest from key opinion leaders to implement HyperCollar3D for Re-radiation of H&N Cancer” The ...
Read More

Gerard van Rhoon receives Robinson Award

Gerard van Rhoon was honored by receiving the 28th J. Eugene Robinson1 award, which is the most prestigious price of ...
Read More

Sarah Brueningk receives Sensius Award at ESHO2017

At ESHO2017 in Athens, Sarah Brueningk received the Sensius Young Investigator Award for her presentation "Simulating response to multimodality therapies ...
Read More

Sensius receives first investment from UNIIQ for the HyperCollar3D

Sensius, an Erasmus MC Spinoff company developing novel cancer treatment using hyperthermia, is receiving €300,000 from the UNIIQ investment fund ...
Read More

Swiss reimburse hyperthermia treatments

Aarau, 1 January 2017 Swiss health authorities have decided to include treatment of cancer through a combination of radiotherapy and ...
Read More

Sensius contributes to control of cost of health care

Den Haag, 1 December 2016 Dutch Cancer Foundation (KWF) has collected 18 innovative ideas to keep cancer treatments economically accessible ...
Read More

Valerio Fortunati wins award based on contribution to HyperCollar3D

Utrecht, 28 November 2016 STW in the Netherlands has attributed Valerio Fortunati with the title “Simon Stevin Gezel 2016”. He ...
Read More

Sensius: “Hyperthermia for H&N can be introduced without additional cost”

Amersfoort, 27 june 2016 At a special event of KWF Kankerbestrijding (DCI) on Business Models for the Future, Sensius presented ...
Read More

Erasmus MC reveals promising early clinical results on HYPERcollar3D

Rotterdam, 15 september 2015 At ESHO 2015 in Zurich, Netteke van Holthe shared early experience with the HYPERcollar3D applicator as ...
Read More

Spin off: Collaboration Erasmus MC and Sensius

Rotterdam, 10 april 2015 Erasmus MC Cancer Institute and Sensius BV have signed an agreement to collaborate on the advancement ...
Read More

Comments are closed.